Adverse Events Following Major Adverse Cardiovascular Events(MACE) in People With COPD: An Analysis of Exacerbations, MACE and Mortality
Anne E Ioannides(Imperial College London), Jennifer K Quint(Roland Hill (United Kingdom)), Emily L. Graul(Emory University)
American Journal of Respiratory and Critical Care Medicine
May 1, 2025
Cited by 0
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
|EBioMedicine|2022|121
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
|Nature Medicine|2023|96
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America
|The Journal of Allergy and Clinical Immunology In Practice|2022|79
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study
|American Journal of Respiratory and Critical Care Medicine|2023|79